ASSOCIATION OF BIOFILM PRODUCTION AND TWITCHING AND SWARMING MOTILITY OF CLINICAL ISOLATES OF ACINETOBACTER BAUMANNII
Abstract
Abstract
Introduction: Acinetobacter baumannii is a ubiquitous Gram-negative bacillus that has emerged as one of the most important cause of healthcare-associated infections primarly due to multidrug resistance and its ability to survive within biofilm on nonliving objects. Acinetobacter posses pili that mediates its adherence to abiotic surfaces and certain types of motility such as twitching and swarming.
Aim: The aim of this study was to determine the capacity of the biofilm production of A. baumannii and the twiching and swarming motility.
Material and methods: A total of 128 strains of A. baumannii isolated from blood (34), wound swabs (35), respiratory tract (39) and other clinical materials (20) were included in the study. Biofilm-producing ability was tested in the microtiter plates at 26°C and 37°C for 24 hours incubation period and at 37°C for 48h incubation as well. The presence of the pili was determined by the testing of the twitching and swarming motility in a semi-solid nutrient medium.
Results: More than 90% of isolates showed moderate or strong biofilm production capacity regardless of the experimental conditions. Decreasing in biofilm production was noticed in the group of strong biofilm producers (p<0.001) during prolonged incubation time (48h). During the 24-hour incubation period, wound and respiratory isolates were significantly more frequent in the group of strong biofilm producers compared to blood and other isolates. No correlation between specific types of motility and biofilm production was noticed.
Conclusion: The biofilm production remained stable under the tested experimental condition. There was no decisive influence of pili on this virulence factor.
Keywords: Acinetobacter baumannii, biofilm, motility, pili
References
Dijkshoorn L, Nemec A, Seifert H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol 2007; 5:939–951.
Poirel L, Nordmann P. Genetic structures at the origin of acquisition and expression of the carbapenem-hydrolyzing oxacillinase gene blaOXA-58 in Acinetobacter baumannii. Antimicrob Agents Chemother. 2006; 50:1442-1448.
Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN, Bonomo RA. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother. 2007; 51:3471-3484.
Karakoc C, Tekin R, Yeşilbağ Z, Cagatay A. Risk factors for mortality in patients with nosocomial Gram-negative rod bacteremia. Eur Rev Med Pharmacol Sci. 2013; 17:951-957.
Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 2002; 15:167-93.
Djeribi R, Boucherit Z, Bouchloukh W et al. A study of pH effects on the bacterial surface physicochemical properties of Acinetobacter baumannii. Colloids Surf B Biointerfaces. 2013; 102:540-545.
Costerton JW, Stewart PS. Battling biofilms. Sci Am 2001; 285:74-81.
Villegas MV, Hartstein A. Acinetobacter outbreaks, 1977-2000. Infect Control Hosp Epidemiol 2003; 24:284-295.
Tomaras AP, Dorsey CW, Edelmann RE, Actis LA. Attachment to and biofilm formation on abiotic surfaces by Acinetobacter baumannii: involvement of a novel chaperone-usher pili assembly system. Microbiology 2003; 149:3473-3484.
Eijkelkamp BA, Stroeher UH, Hassan KA, Papadimitrious MS, Paulsen IT, Brown MH. Adherence and motility characteristics of clinical Acinetobacter baumannii isolates. FEMS Microbiol Lett 2011; 323:44-51.
Subramaniyan A. Profile of multidrug resistant Acinetobacter baumannii infections among hospitalized patients. J Med Sci Clin Res 2017; 5:23111-23115.
Dunne WM Jr. Bacterial adhesion: seen any good biofilms lately? Clin Microbiol Rev. 2002 Apr; 15:155-66.
McQueary CN, Actis LA. Acinetobacter baumannii biofilms: variations among strains and correlations with other cell properties. J Microbiol. 2011; 49:243-50.
Stepanovic S, Vukovic D, Dakic I, Savic B, Svabic-Vlahovic M. A modified microtiter-plate test for quantification of staphylococcal biofilm formation. J Microbiol Methods 2000; 40:175-9.
Clemmer KM, Bonomo RA, Rather PN. Genetic analysis of surface motility in Acinetobacter baumannii. Microbiology 2011; 157:2534–2544.
Wu H, Moser C, Wang HZ, Høiby N, Song ZJ. Strategies for combating bacterial biofilm infections. Int J Oral Sci. 2015; 7:1-7.
Rosini R, Margarit Biofilm formation by Streptococcus agalactiae: influence of environmental conditions and implicated virulence factors. Front Cell Infect Microbiol. 2015; 5:6.
Toyofuku M, Inaba T, Kiyokawa T, Obana N, Yawata Y, Nomura N. Environmental factors that shape biofilm formation. Biosci Biotechnol Biochem 2015; 80:7-12.
Fiedler T, Köller T, Kreikemeyer B. Streptococcus pyogenes biofilms-formation, biology, and clinical relevance. Front Cell Infect Microbiol 2015; 5:15.
De Breij A, Dijkshoorn L, Lagendijk E, et al. Do biofilm formation and interactions with human cells explain the Clinical Success of Acinetobacter baumannii? PLoS One. 2010; 5:e10732.
Obeidat N, Jawdat F, Al-Bakri AG, Shehabi AA. Major biologic characteristics of Acinetobacter baumannii isolates from hospital environmental and patients’ respiratory tract sources. Am J Infect Control 2014; 42:401-4.
Longo F, Vuotto C, Donelli G. Biofilm formation in Acinetobacter baumannii. New Microbiol 2014; 37:119-27.
Sanchez CJ Jr, Mende K, Beckius ML, Akers KS, Romano DR, Wenke JC, Murray CK. Biofilm formation by clinical isolates and the implications in chronic infections. BMC Infect Dis. 2013; 13:47.
Vijayakumar S, Rajenderan S, Laishram S, Anandan S, Balaji V, Biswas I. Biofilm formation and motility depend on the nature of the Acinetobacter baumannii clinical isolates. Front Public Health 2016; 4:105.
Kostakioti M, Hadjifrangiskou M, Hultgren SJ. Bacterial biofilms: development, dispersal, and therapeutic strategies in the dawn of the postantibiotic era. Cold Spring Harb Perspect Med. 2013; 3:a010306.
Chow S, Gu K, Jiang L, Nassour A. Salicylic acid affects swimming, twitching and swarming motility in Pseudomonas aeruginosa, resulting in decreased biofilm formation. J Exp Microbiol Immunol 2011; 15:22–29.